Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


IIVI Incorporated (Nasdaq: IIVI), a leading provider of imaging optics, today announced the introduction of its diffraction-limited apochromatic objective lenses for fluorescence imaging.


GlobeNewswire Inc | Feb 10, 2021 08:30AM EST

February 10, 2021

PITTSBURGH, Feb. 10, 2021 (GLOBE NEWSWIRE) -- IIVI Incorporated (Nasdaq: IIVI), a leading provider of imaging optics, today announced the introduction of its diffraction-limited apochromatic objective lenses for fluorescence imaging.

The rapidly growing number of life sciences instruments, including fluorescence-based imaging systems, flow cytometers, and DNA sequencers, is driving the demand for precision optics that enable greater imaging resolution across the full visible spectrum. II-VIs new apochromatic objective lenses achieve subwavelength surface regularity and exceptionally high optical transmission to enable diffraction-limited performance, making them well-suited for a broad range of life sciences instrumentation platforms.

We pushed the limits of precision manufacturing and metrology to achieve diffraction-limited optics that are highly desirable for apochromatic imaging in next-generation fluorescence-based instrumentation platforms, said Dr. Guanglong Yu, Vice President, Advanced Optics Business Unit. Now, customers can leverage these leading capabilities, together with our broad portfolio of related components, our rapid turnaround time on custom designs, and our global footprint of ISO-certified life sciences assembly facilities, to realize their next-generation instrumentation platforms, followed by a seamless transfer to high-quality manufacturing at scale.

II-VIs broad portfolio of products for instrumentation in life sciences includes visible-wavelength lasers and laser systems, precision optics, filters, and assemblies, as well as thermoelectric modules. System providers can expand assembly manufacturing at II-VIs facilities in Dallas, Texas; Fuzhou, China; and Ho Chi Minh City, Vietnam, which are certified to ISO 13485 for biomedical assemblies.

II-VI will showcase its broad product line of optics and lasers for life sciences at the 2021 SPIE BiOS Digital Marketplace, March 6-11, 2021.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

CONTACT: Mark Lourie Vice President, Corporate Communications corporate.communications@ii-vi.com www.ii-vi.com/contact-us







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC